These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4195576)

  • 1. L-dopa, parkinsonism, and depression.
    Damásio AR; Antunes JL; Macedo C
    Lancet; 1970 Sep; 2(7673):611-2. PubMed ID: 4195576
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of L-dopa on the seborrhoea of Parkinsonism.
    Burton JL; Cartlidge M; Shuster S
    Br J Dermatol; 1973 May; 88(5):475-9. PubMed ID: 4268445
    [No Abstract]   [Full Text] [Related]  

  • 3. Emotional functions in short-term vs. long-term L-Dopa therapy in Parkinsonism.
    Maskin MB; Riklan M; Chabot D
    J Clin Psychol; 1973 Oct; 29(4):493-5. PubMed ID: 4148857
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal of the glabellar reflex in Parkinsonism by L-dopa.
    Klawans HL; Goodwin JA
    J Neurol Neurosurg Psychiatry; 1969 Oct; 32(5):423-7. PubMed ID: 5360050
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of severe parkinsonism with L-dopa.
    Reef HE; Joffe R; Milletz H
    S Afr Med J; 1971 May; 45(18):504-7. PubMed ID: 4941208
    [No Abstract]   [Full Text] [Related]  

  • 6. [Psychological status of patients with Parkinsonism during treatment with amantadine hydrochloride and L-Dopa].
    Ferraris M
    Minerva Med; 1971 Oct; 62(82):3971-3. PubMed ID: 5125056
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of treatment of Parkinsonism with L-dopa].
    De Divitiis E; D'Andrea F; Signorelli CD
    Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563
    [No Abstract]   [Full Text] [Related]  

  • 8. [L-5-hydroxytryptophan(L-5-HTP) therapy of Parkinson's disease. 2].
    Sano I; Taniguchi K
    Munch Med Wochenschr; 1972 Oct; 114(40):1717-9. PubMed ID: 4538893
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of L-dopa on seborrhoea of parkinsonism.
    Wyburn-Mason R
    Lancet; 1970 Jul; 2(7664):154. PubMed ID: 4194540
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of L-dopa on seborrhoea of parkinsonism.
    Burton JL; Shuster S
    Lancet; 1970 Jul; 2(7662):19-20. PubMed ID: 4193751
    [No Abstract]   [Full Text] [Related]  

  • 11. Parkinsonism, L-dopa and mental depression.
    Cherington M
    J Am Geriatr Soc; 1970 Jul; 18(7):513-6. PubMed ID: 5421784
    [No Abstract]   [Full Text] [Related]  

  • 12. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
    Antonini F; Baroni A; Roveyaz L
    Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560
    [No Abstract]   [Full Text] [Related]  

  • 13. L-Dopa for Parkinsonism.
    Cotzias GC
    N Engl J Med; 1968 Mar; 278(11):630. PubMed ID: 5637779
    [No Abstract]   [Full Text] [Related]  

  • 14. Progressive external ophthalmoplegia with Parkinsonism and Dementia. Treatment with L-dopa. Report of an autopsied case.
    Rajput AH; Chornell G; Rozdilsky B
    Can J Ophthalmol; 1972 Jul; 7(3):368-74. PubMed ID: 5056570
    [No Abstract]   [Full Text] [Related]  

  • 15. [Quantitative testing methods for objectification of the effect of prolonged L-dopa therapy in parkinsonism].
    Gerstenbrand F; Grünberger J; Schubert H
    Nervenarzt; 1973 Aug; 44(8):428-33. PubMed ID: 4733895
    [No Abstract]   [Full Text] [Related]  

  • 16. Depressive syndromes and L-dopa treatment in Parkinsonian patients.
    Pinelli P; Pinto F; Mazza S
    Arch Psicol Neurol Psichiatr; 1971; 32(5):414-26. PubMed ID: 5145648
    [No Abstract]   [Full Text] [Related]  

  • 17. L-dopa in Parkinsonism.
    J Indian Med Assoc; 1969 Dec; 53(12):606-7. PubMed ID: 5364711
    [No Abstract]   [Full Text] [Related]  

  • 18. L-dopa in parkinsonism.
    Nahum LH
    Conn Med; 1970 Jun; 34(6):396-8. PubMed ID: 5431102
    [No Abstract]   [Full Text] [Related]  

  • 19. L-dopa and Parkinsonism.
    Lond Clin Med J; 1970 Jan; 11(1):5-7. PubMed ID: 5504130
    [No Abstract]   [Full Text] [Related]  

  • 20. DOPA-responsive dystonic parkinsonism--pathophysiologic considerations.
    Segawa M; Nishiyama N; Nomura Y
    Adv Neurol; 1999; 80():389-400. PubMed ID: 10410746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.